Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Profit Margin

The latest profit margin for SRNGU is -314.76% as of June 2026. That compares with -136.56% in the prior-year period — down 130.5% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SRNGU's profit margin moved from -136.56% to -314.76% — a 130.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s valuation or profitability profile.

Against Healthcare companies, SRNGU currently prints -314.76% for profit margin, while the sector average sits near 14.34%. That is roughly 2294.2% below the sector mean. Large gaps often invite a closer look at Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) converts resources into returns. At -314.76%, SRNGU may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -136.56% in the prior-year period — down 130.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SRNGU's profit margin (-314.76%), review year-over-year change from -136.56%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.